MSLN and uterine cancer: For example, theanti-MSLN ADC agent, Anetumab ravtansine, was evaluated in a mousemodel of uterine cancer, and it was found that only tumors with highMSLN expression demonstrated a compete response.23 PET imaging can be used to assess MSLN expression withintumors.